Electronic health records can help identify triggers for advance care planning that align with optimal timing windows, mainly ...

Rules that allow for this expanded scope without requiring physician collaboration vary by state. Currently in the US, 27 ...

A chemotherapy-free-based regimen of the TKI ponatinib combined with targeted immunotherapy showed significant benefits in ...

A backlash against pandemic-era restrictions, online misinformation, and a lack of resources for healthcare have contributed ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

Intestinal ultrasound is highly acceptable and well tolerated by patients with inflammatory bowel disease, reflecting strong ...

Over-the-counter medicines were the most frequent treatment choice for 16 symptoms, with the highest use for headaches (63.2% ...

The first-of-its kind gene therapy uses a patient’s skin cells to create sheets to treat the open wounds caused by the rare, ...

Cannabis hyperemesis prevalence rose sharply during the COVID-19 pandemic and remains elevated in the US, a study finds.

In the phase 3 COBRA trial, the carfilzomib/lenalidomide/dexamethasone regimen shows significant improvements in PFS and other outcomes in newly diagnosed MM, including in patients at cytogenic risk.

The remission of childhood overweight before young adulthood reverses the risk for coronary heart disease in adulthood; however, gaining weight during puberty significantly increases the future risk.

Emulsifiers are among the most common food additives. But they appear to negatively affect GI health. Should patients with GI conditions stop eating these nearly ubiquitous products?